Organ-on-a-chip Market Worth USD 170 million by 2023 | CAGR:62.9%
Organ-on-a-chip is a multi-channel 3D microfluidic cell culture chip that imitate the mechanics, activities and physiological response of total organs andorgan systems, a type of artificial o
Organs-On-Chips Market report segments into type, key developments, application, Competitive , end user, and regional analysis.Organ-on-a-chip chip develops a thin channel for the blood and air movement in organs such as for example liver, lung, heart, gut, and others. Such devices produce multiple quantities of tissue and organ functionalities, that aren't feasible using conventional 2D and 3D culture systems.Organ. Examine with organs-on-chips lies in the isolation of organs during evaluate.Organ-on-chip Market size is expected to reach $170 million by 2023, and was valued at $5 million in 2016, registering a CAGR of 62.9% from 2017 to 2023.
Key Developments
Major players in the market are focused on various business strategies such as merger and acquisition, in order to enhance their market presence. For instance, in March 2018, BioIVT acquired Ascendance Biotechnology to expand its drug safety testing and toxicology portfolios.
Whereas, in November 2018, BioIVT acquired Biological Specialty Corporation (BSC), which will expand its ability to offer fresh blood products.
Major players available in the market are pay attention to various business ideas such as for example hosting conferences, research symposium, and events, to be able to showcase recent research advances in the market.
Comments
Post a Comment